Search

Author/Creator Fox, Elizabeth

2. A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group. Issue 8 (25th April 2018)

Authors:
Chuk, Meredith K.; Widemann, Brigitte C.; Minard, Charles G.; Liu, Xiaowei; Kim, AeRang; Bernhardt, Melanie Brooke; Kudgus, Rachel A.; Reid, Joel M.; Voss, Stephan D.; Blaney, Susan; Fox, Elizabeth; Weigel, Brenda J.
Journal:
Pediatric blood & cancer
Issue:
Volume 65:Issue 8(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A phase 1 study of entinostat in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1513, Pediatric Early Phase‐Clinical Trial Network (PEP‐CTN). Issue 4 (12th January 2021)

Authors:
Bukowinski, Andrew; Chang, Bill; Reid, Joel M.; Liu, Xiaowei; Minard, Charles G.; Trepel, Jane B.; Lee, Min‐Jung; Fox, Elizabeth; Weigel, Brenda J.
Journal:
Pediatric blood & cancer
Issue:
Volume 68:Issue 4(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A phase 1 study of eribulin mesylate (E7389), a novel microtubule‐targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314). Issue 8 (2nd May 2018)

Authors:
Schafer, Eric S.; Rau, Rachel E.; Berg, Stacey; Liu, Xiaowei; Minard, Charles G.; D'Adamo, David; Scott, Rachael; Reyderman, Larisa; Martinez, Gresel; Devarajan, Sandhya; Reid, Joel M.; Fox, Elizabeth; Weigel, Brenda J.; Blaney, Susan M.
Journal:
Pediatric blood & cancer
Issue:
Volume 65:Issue 8(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515). Issue 9 (21st April 2021)

Authors:
Cash, Thomas; Fox, Elizabeth; Liu, Xiaowei; Minard, Charles G.; Reid, Joel M.; Scheck, Adrienne C.; Weigel, Brenda J.; Wetmore, Cynthia
Journal:
Pediatric blood & cancer
Issue:
Volume 68:Issue 9(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A phase 1 study of the c‐Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111). Issue 11 (27th April 2017)

Authors:
Geller, James I.; Perentesis, John P.; Liu, Xiaowei; Minard, Charles G.; Kudgus, Rachel A.; Reid, Joel M.; Fox, Elizabeth; Blaney, Susan M.; Weigel, Brenda J.
Journal:
Pediatric blood & cancer
Issue:
Volume 64:Issue 11(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. A phase 1 trial of temsirolimus and intensive re‐induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114). (14th March 2017)

Authors:
Rheingold, Susan R.; Tasian, Sarah K.; Whitlock, James A.; Teachey, David T.; Borowitz, Michael J.; Liu, Xiaowei; Minard, Charles G.; Fox, Elizabeth; Weigel, Brenda J.; Blaney, Susan M.
Journal:
British journal of haematology
Issue:
Volume 177:Number 3(2017)
Page Start:
467
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315). Issue 23 (5th November 2018)

Authors:
Geller, James I.; Fox, Elizabeth; Turpin, Brian K.; Goldstein, Stuart L.; Liu, Xiaowei; Minard, Charles G.; Kudgus, Rachel A.; Reid, Joel M.; Berg, Stacey L.; Weigel, Brenda J.
Journal:
Cancer
Issue:
Volume 124:Issue 23(2018)
Page Start:
4548
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. ACCELERATE Paediatric Strategy Forums: an advance for oncological drug development?. Issue 11 (November 2022)

Authors:
Pearson, Andrew D J; Rojas, Teresa de; Karres, Dominik; Reaman, Gregory; Scobie, Nicole; Fox, Elizabeth; Lesa, Giovanni; Ligas, Franca; Norga, Koen; Nysom, Karsten; Pappo, Alberto; Weigel, Brenda; Weiner, Susan; Vassal, Gilles
Journal:
Lancet oncology
Issue:
Volume 23:Issue 11(2022)
Page Start:
1354
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. ACCELERATE – Five years accelerating cancer drug development for children and adolescents. (May 2022)

Authors:
Pearson, Andrew D.J.; Weiner, Susan L.; Adamson, Peter C.; Karres, Dominik; Reaman, Gregory; Rousseau, Raphaël; Blanc, Patricia; Norga, Koen; Skolnik, Jeffrey; Kearns, Pam; Scobie, Nicole; Barry, Elly; Marshall, Lynley V.; Knox, Leona; Caron, Hubert; Wariabharaj, Darshan; Pappo, Alberto; DuBois, ...
Journal:
European journal of cancer
Issue:
Volume 166(2022)
Page Start:
145
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗